A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma

NCT01842594 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
13
Enrollment
OTHER
Sponsor class

Stopped Most patients completed only the primary objective (PET) and not went throught the secondary outcome (efficacy phase) of 8wks period.

Conditions

Interventions

Sponsor

Shin Kong Wu Ho-Su Memorial Hospital